Malaria Risk Factors in Women on Intermittent Preventive Treatment at Delivery and Their Effects on Pregnancy Outcome in Sanaga-Maritime, Cameroon

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Tonga, Calvin ^a   Kimbi, Helen Kuokuo ^a   Anchang Kimbi, Judith Kuoh ^a   Nyabeyeu, Hervé Nyabeyeu ^b   Bissemou, Zacharie Bissemou ^c   Lehman, Léopold G ^b  

^a UNIVERSITY OF BUEA   (Cameroon)

^b UNIVERSITY OF DOUALA   (Cameroon)

^c Pouma District Hospital   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PYRIMETHAMINE; SULFADOXINE;

ADOLESCENT; ADULT; AGE; ARTICLE; BED NET; BIRTH WEIGHT; BLOOD ANALYSIS; CAMEROON; DELIVERY; DRUG INTERMITTENT THERAPY; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMITTENT PREVENTIVE TREATMENT; LOWEST INCOME GROUP; MALARIA; NEWBORN; NEWBORN INFECTION; PLACENTA; PLACENTA MALARIA; PLASMODIUM; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PREVALENCE; PRIMIPARA; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; UMBILICAL CORD BLOOD; DRUG COMBINATION; FETUS; GROWTH, DEVELOPMENT AND AGING; MALARIA, FALCIPARUM; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; SOCIAL CLASS;

ADOLESCENT; ADULT; ANTIMALARIALS; CAMEROON; DRUG COMBINATIONS; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; MALARIA, FALCIPARUM; MIDDLE AGED; MOSQUITO NETS; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; PREVALENCE; PYRIMETHAMINE; RISK FACTORS; SOCIAL CLASS; SULFADOXINE;

EID: 84878784348     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065876     Document Type: Article

References (50)

1. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO, (2010) Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med 7: e1000221.
2. Mockenhaupt PF, Bedu-Addo G, Jungle C, Hommerich L, Eggelte TA, et al. (2007) Markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women. Antimicrob Agents Chemother 51 (1): 332-334.
3. Uneke CJ, (2007) Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in Sub-Saharan Africa. I: Introduction to Placental Malaria. Yale's Journal of Biology and Medicine 80 (2): 39-50.
4. Marchesini P, Crawley J (2004) Reducing the burden of malaria in pregnancy. MERA IV, supporting agency - Roll Back Malaria, WHO.
5. WHO (2004) A strategic framework for malaria prevention and control during pregnancy in the African region. WHO Regional Office for Africa, Brazzaville, AFR/MAL/O4/01.
6. Vallely A, Vallely L, Changalucha J, Greenwood B, Chandramohan D, (2007) Intermittent preventive treatment for malaria in pregnancy in Africa. What's new, what's needed? Malar J 6: 16.
7. Mbacham WF, Evehe MSB, Netongo PM, Ateh IA, Mimche PN, Ajua, et al. (2010) Efficacy of Amodiaquine, Sulfadoxine-Pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to Artemisinin-based combination therapy. Malar J 9: 34.
8. WHO (2010) Global report on antimalarial drug efficacy and drug resistance, 2000-2010. World Health Organization, 20 Avenue Appia, 1211 Geneva, Switzerland.
9. Lin TL, Mbewe B, Taylor SM, Luntamo M, Meshnick SR, et al. (2012) Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria. Trop Med Int Health In press.
10. Anchang-Kimbi JK, Achidi EA, Nkegoum B, Sverremark-Ekström E, Troye-Blomberg M, (2009) Diagnostic comparison of malaria infection in peripheral blood, placental blood and biopsies in Cameroonian parturient women. Malar J 8: 126.
11. Leke RGF, Bioga JD, Zhou J, Fouda GG, Leke RJI, et al. (2010) Longitudinal studies of Plasmodium falciparum malaria women living in a rural Cameroonian village with high perennial transmission. Am J Trop Med Hyg 83 (5): 996-1004.
12. Achidi AE, Anchang JK, Minang TJ, Boyo MA, Sinju CM, et al. (2005) Malaria infection in pregnancy and its effect on haemoglobin levels in women from a malaria endemic area of Fako Division, South West Province, Cameroon. J Obstet Gynaecol 25: 235-240.
13. Tako AE, Zhou A, Lohoue J, Leke R, Taylor DW, et al. (2005) Risk factors for placental malaria and its effect on pregnancy outcome in Yaoundé, Cameroon. Am J Trop Med Hyg 72 (3): 236-242.
14. Fievet N, Tami G, Maubert B, Moussa M, Shaw IK, et al. (2002) Cellular immune response to Plasmodium falciparum is related to previous placental infection and parity. Malar J 1 (16).
15. Achidi EA, Minang JT, Kuoh AJ, Ahmadou MJ, Troye-Blomberg M, (2005) Plasmodium falciparum inhibitory capacities of paired maternal-cord sera from South-west Province, Cameroon. Journal of Tropical pediatrics 51 (3): 182-190.
16. Tutterrow YL, Salanti A, Avril M, Smith JD, Pagano IS, et al. (2012) High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria. PLoS ONE 7 (6): e40049.
17. Omalu ICJ, Mgbemena C, Mgbemena A, Ayanwale V, Olayemi IK, et al. (2012) Prevalence of congenital malaria in Minna, north central Nigeria. Journal of Tropical Medicine 2012: 274142.
18. Cheesbrough M (2000) Parasitological tests in district laboratory practice in tropical countries part 2. Cambridge Low- price editions, Cambridge University Press.
19. Allen SJ, Bennet REM, Rowe PA, Jacosen PH, O'Donnell A, et al. (1992) Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in the Gambia. Trans Rev Soc Trop Med Hyg 86: 491-498.
20. Barduagni P, Ahmed AS, Curtale F, Raafat M, Soliman L, (2003) Performance of Sahli and colour scale methods in diagnosing anaemia among school children in low prevalence areas. Trop Med Int Health 8 (7): 615-618.
21. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, et al. (2007) Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7: 93-104.
22. Iriemenam NC, Shah M, van Eijk AM, Ayisi J, Kariuki S, et al. (2012) Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J 11: 134.
23. Mokuolu OA, Falade CO, Orogade AA, Okafor HU, Adedoyin OT, et al. (2009) Malaria at parturition in Nigeria: current status and delivery outcome. Infectious Diseases in Obstetrics and Gynecology 2009: 473971.
24. Ouédraogo A, Tiono AB, Diarra A, Bougouma ECC, Nébié I, et al. (2012) Transplacental transmission of plasmodium falciparum in highly malaria endemic area of Burkina Faso. Journal of Tropical Medicine 2012: 109705.
25. Mockenhaupt FP, Ulmen U, von Gaertner C, Bedu-Addo G, Bienzle U, (2002) Diagnosis of placental malaria. J Clin Microbiol 40 (1): 306-308.
26. Brabin BJ, Romagosa C, Abdelgalil S, Menéndez C, Verhoeff FH, et al. (2004) The sick placenta- The role of malaria. Placenta 25: 359-378.
27. Walker-Abbey A, Djokam RRT, Eno A, Leke RFG, Titanji VPK, et al. (2005) Malaria in pregnant Cameroonian women: the effect of age and gravidity on submicroscopic and mixed-species infections and multiple parasite genotypes. Am J Trop Med Hyg 72 (3): 229-235.
28. Manirakiza A, Serdouma E, Djalle D, Soula G, Laganier R, et al. (2011) Relatively low prevalence of peripheral and placental Plasmodium infection at delivery in Bangui, Central African republic. Journal of Tropical Medicine 2011: 434816.
29. Steketee RW, Nahlen BL, Parise ME, Menendez C, (2001) The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 64 (Suppl 1): 28-35.
30. Achidi AE, Kuoh AJ, Minang JT, Achimbom BM, Ahmadou MJ, et al. (2005) The effect of maternal, umbilical cord and placental malaria parasitaemia on the birth weight of newborns from south-western Cameroon. Acta Paediatrica 94: 917-923.
31. Xi G, Leke RGF, Thuita LW, Zhou A, Leke RJI, et al. (2003) Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in utero-produced antimalarial immunoglobulin M antibodies. Infection and Immunity 71 (3): 1242-1246.
32. Anchang-Kimbi JK (2010) Influence of placental malaria infection on pregnancy outcome and Plasmodium falciparum isotypic antibody levels in paired maternal-cord blood in the Mount Cameroon area. PhD thesis, University of Buea.
33. Mosha JF, Conteh L, Tediosi F, Gesase S, Bruce J, et al. (2010) Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS ONE 5 (1): e8707.
34. Osungbade KO, Oladunjoye OO, (2012) Prevention of congenital transmission of malaria in sub-Saharan countries: challenges and implications for health system strengthening. Journal of Tropical Medicine 2012: 648456.
35. Uneke CJ, (2007) Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in Sub-Saharan Africa. II: Effects of placental malaria on perinatal outcome; Malaria and HIV. Yale Journal of Biology and Medicine 80 (3): 95-103.
36. Adebami OJ, Owa JA, Oyedeji GA, Oyelami OA, Omoniyi-Esan GO, (2007) Association between placental and cord blood. Am J Trop Med Hyg 77 (2): 209-213.
37. Mbu ER, Kongnyuy EJ, Mbopi-Keou FX, Tonye RN, Nana PN, et al. (2008) Gynaecological morbidity among HIV positive pregnant women in Cameroon. Reproductive Health 5 (3).
38. Flateau C, Le Loup G, Pialoux G, (2011) Consequences of HIV infection on malaria and therapeutic implications: A systematic review. Lancet Infect Dis 11: 541-556.
39. González R, Ataíde R, Naniche D, Menéndez C, Mayor A, (2012) HIV and malaria interactions: where do we stand? Expert Rev Anti Infect Ther 10 (2): 153-165.
40. Mount AM, Mwapasa V, Elliott SR, Beeson JG, Tadesse E, et al. (2004) Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. The Lancet 363: 1860-67.
41. Monebenimp F, Ella NGE, Zoung-Kany BAN, Chelo D, Tetanye E, (2011) HIV exposure and related newborn morbidity and mortality in the University Teaching Hospital of Yaoundé, Cameroon. Pan African Medical Journal 8 (43).
42. Uneke CJ, (2008) Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in Sub-Saharan Africa. III: Placental malaria, maternal health and public health. Yale Journal of Biology and Medicine 81 (1): 1-7.
43. Falade CO, Yusuf BO, Fadero FF, Mokuolo OA, Hamer DH, et al. (2007) Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, South-Western Nigeria. Malar J 6: 88.
44. National Institute of Statistics (2011) Enquête démographique et de santé et à indicateurs multiples. Rapport préliminaire. National Institute of Statistics, Yaoundé-Cameroon.
45. Takem EN, Achidi AE, Ndumbe PM, (2009) Use of intermittent preventive treatment for malaria by pregnant women in Buea, Cameroon. Acta Tropica 112: 54-58.
46. Napoleon RP, Anyangu AS, Omolocan J, Ongus JR, (2011) Preventing malaria during pregnancy: factors determining the use of insecticide-treated bed-nets and intermittent preventive therapy in Juba. SSMJ 4 (2): 33-38.
47. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE, (2011) Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. CID 53 (3): 224-230.
48. Tutu EO, Lawson B, Browne E, (2011) The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso District of Ashanti Region, Ghana. Malar J 10: 385.
49. Umeh UA, Obi SN, Onah HE, Ugwu EOV, Ajah LO, et al. (2012) The impact of intermittent preventive treatment with sulphadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy. Tropical Doctor 00: 1-3.
50. Ringwald P, Keundjian A, Same-Ekobo A, Basco LK, (2011) Chimiorésistance de P. falciparum en milieu urbain à Yaoundé, Cameroun. Part 2: Evaluation de l'efficacité de l'amodiaquine et de l'association sulfadoxine-pyriméthamine pour le traitement de l'accès palustra simple à Plasmodium falciparum à Yaoundé, Cameroun. TMIH 5 (9): 620-627.